CSF3R and central nervous system cancer: In glioma tumors from the TCGA-LGG dataset, a poorer patient prognosis as assessed by shorter OS was significantly associated with high CSF3R/CD114 expression when all tumor types were polled together (Figure 5A), as well as when astrocytoma (n = 194), oligoastrocytoma (n = 130), and oligodendroglioma (n = 189) tumors were analyzed separately (Figure 5B–D).